Technology

Branded ACS Therapies to Grab Market Share from Generics, Says Report

September 02, 2015.

NHS England Survey: Staff Struggling With Severe Financial Pressure

September 2, 2015.

More Than Half US Physicians Place Moderate-to-Severe Restrictions on Pharma Sales Reps

September 02, 2015.

What Time is It? Time to Get a Wearable Strategy

September 02, 2015.

Peter Houston

September 1st 2015

The success of Apple's iWatch is part of the apparently unstoppable rise of wearable technology, in particular health and fitness applications, writes Peter Houston.

New Actos Trial Begins in Las Vegas

FDA Releases Guidance on Biosimilar Naming

August 28, 2015.

Randi Hernandez

GSK to Divest Ofatumumab to Novartis Pharma

August 28, 2015.

Perrigo Confident Shareholders "Will Reject Mylan's Value Destructive Transaction"

GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.

Novo Nordisk to Start Phase III Trial for Oral Biologic

August 28, 2015.

Randi Hernandez

August 27th 2015

August 27, 2015.

Pfizer to Divest Four Injectable Products in Hospira Acquisition

August 27th 2015

August 27, 2015.

US Rep. Introduces Product Information Modernization Bill

August 26th 2015

August 26, 2015.

Mylan Responds to Perrigo's "Misleading Statements"

August 26th 2015

August 26, 2015.

Researchers Move Closer to Universal Flu Vaccine

August 25, 2015.

AZ Finds New CMO

Industry Responds to FDA Metrics Program

August 25, 2015.

Jill Wechsler, Pharm Exec’s Washington Correspondent

Brazil’s Pharmaceutical Market Value to Approach $48 Billion by 2020

Manufacturers seek gradual rollout of more targeted FDA quality metrics program.

FDA Approval Hails Arrival of the 3-D Printed Drug

August 25, 2015.

August 24th 2015

August 24, 2015.

Bayer UK Chief Calls for Britain to Stay in European Union

August 24th 2015

August 24, 2015.

Pharma Invests in Companion Diagnostics

Applied Clinical Trials Editorial Staff

Sunshine: Pushing Research Out of US?

August 20, 2015.

Applied Clinical Trials

Global Multiple Myeloma Treatment Market Value to Approach $9 Billion by 2021

August 20, 2015.

Pharma Dealmaking, Venture Funding Going Strong in 2015, Says Review

August 20, 2015.